Can facial flushing occur with Wellbutrin (bupropion) and what should be done?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Facial Flushing with Wellbutrin (Bupropion)

Facial flushing is not a recognized or documented adverse effect of bupropion (Wellbutrin) in FDA labeling or clinical guidelines, but if it occurs, consider hypersensitivity reactions or other dermatologic manifestations that may require immediate discontinuation.

What the FDA Label Reports

The FDA prescribing information for Wellbutrin documents facial edema as a postmarketing adverse reaction, but does not list facial flushing as a known side effect 1. The documented dermatologic reactions include:

  • Hypersensitivity reactions characterized by pruritus, urticaria, angioedema, skin rash, and in rare cases erythema multiforme and Stevens-Johnson syndrome 1
  • Facial edema reported in postmarketing surveillance 1
  • Delayed allergic reactions that can manifest as urticaria and angioedema, sometimes appearing 2 or more weeks after initiation 2

Clinical Approach to Facial Flushing on Bupropion

Immediate Assessment

  • Evaluate for hypersensitivity reactions: Look specifically for accompanying pruritus, urticaria, angioedema (lip/tongue swelling), dyspnea, chest pain, or rash—these indicate a potentially serious allergic reaction requiring immediate discontinuation 1
  • Check for facial edema versus true flushing: Facial edema (non-pitting swelling) is documented with bupropion, whereas true vasodilatory flushing is not 1
  • Assess timing: Delayed hypersensitivity reactions to bupropion can occur 18-28 days after initiation, not just in the first week 2, 3

When to Discontinue Immediately

Discontinue bupropion and provide antihistamine/corticosteroid treatment if any of the following are present:

  • Urticaria, pruritus, or angioedema accompanying the facial symptoms 1
  • Progressive swelling of the face, lips, or tongue 3
  • Any respiratory symptoms or dyspnea 1
  • Development of rash on other body areas 2, 4

Management of Confirmed Hypersensitivity

  • Stop bupropion immediately—do not wait for symptoms to worsen 1, 3
  • Treat with antihistamines (cetirizine 10 mg daily or levocetirizine) and consider corticosteroids (methylprednisolone) for moderate-to-severe reactions 2, 4
  • Monitor for progression: Symptoms typically resolve within 2 weeks of discontinuation 2, 4
  • Do not rechallenge with the same formulation if a hypersensitivity reaction occurred 1

Alternative Explanations for Facial Flushing

If true flushing (not edema) occurs without other hypersensitivity features, consider:

  • Concurrent medications or substances: Bupropion has no known mechanism to cause vasodilatory flushing 5
  • Hypertension: Bupropion can elevate blood pressure (mean increase 1.3 mmHg systolic), which may manifest as facial flushing in susceptible individuals 1
  • Unrelated causes: Hot flashes, rosacea, or other dermatologic conditions—bupropion does not treat or cause hot flashes 6

Risk Factors for Bupropion Hypersensitivity

  • Males aged 17-40 years appear to have higher risk 2
  • History of allergic reactions to other medications 2
  • Delayed onset (2-4 weeks after initiation) is characteristic of bupropion hypersensitivity 2, 4, 3

Formulation Considerations

  • One case report documented tolerance of bupropion SR after a severe delayed hypersensitivity reaction to bupropion XL, suggesting formulation-specific excipients may play a role 4
  • However, this approach should only be attempted after complete resolution of symptoms and with close monitoring, not as a routine strategy 4

Common Pitfalls

  • Underrecognition of delayed reactions: Clinicians may not attribute symptoms appearing 3-4 weeks after initiation to bupropion 2
  • Failure to document discontinuation: In one case, progression to severe angioedema occurred because the treating clinician did not document or recommend stopping bupropion despite emergency department visits 3
  • Confusing facial edema with benign flushing: Facial edema is a documented adverse effect and may herald more serious hypersensitivity 1

References

Research

Bupropion-induced angioedema.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Guideline

Bupropion Initiation and Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Pilot evaluation of bupropion for the treatment of hot flashes.

Journal of palliative medicine, 2006

Related Questions

How should I manage an allergic reaction with itching and oral tingling after taking bupropion XL?
What message should I send to a patient who experienced an allergic reaction (itching and oral tingling) to bupropion XL, including instructions to stop the medication, use a second‑generation antihistamine, monitor for airway swelling, administer epinephrine if needed, consider a short course of oral prednisone, and discuss alternative antidepressants?
What to do if a patient develops hives after starting Wellbutrin (bupropion)?
How should I manage medication when bupropion (Wellbutrin) is no longer effective?
What are the side effects of Wellbutrin XL (bupropion) 150 mg?
Is nitroglycerin effective for treating diffuse esophageal spasm?
Are there any drug‑drug interactions between atomoxetine (Strattera) and quetiapine (Seroquel), venlafaxine (Effexor), ropinirole, and mirtazapine (Remeron)?
Can buspirone be used for trichotillomania, and what is the appropriate dosing and monitoring?
What are the recommended antibiotics for acute infectious colitis in adults based on the likely bacterial or parasitic pathogen?
What are the differences between Depakote ER (extended‑release valproic acid) and Depakote DR (delayed‑release valproic acid) and what counseling advice should be provided?
What quetiapine (Seroquel) dosing is recommended for a patient with depression with psychotic features who is currently on quetiapine 100 mg daily and escitalopram 15 mg daily and continues to hear voices, according to CANMAT guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.